INS and Atrophy: In the present study, we showed that diabetic complications—induced upon an injection of 40 mg of STZ per kg body weight—resulted in muscle atrophy in our model, which was characterized by polyphagia and resulted in decreased plasma insulin levels and increased blood glucose levels, followed by a reduction in the body weight.